The trading price of Microbot Medical Inc (NASDAQ:MBOT) remained unchanged on Tuesday, March 04, and closing at $1.36.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.38 and a 52-week low of $0.82. Over the past month, the stock has lost -26.09% in value.
Microbot Medical Inc, whose market valuation is $47.25 million at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest MBOT has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned MBOT a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Microbot Medical Inc (MBOT) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that MBOT’s price is currently -25.85% off the SMA20 and -21.15% off the SMA50. The RSI metric on the 14-day chart is currently showing 36.63, and weekly volatility stands at 9.46%. When measured over the past 30 days, the indicator reaches 11.01%. Microbot Medical Inc (NASDAQ:MBOT)’s beta value is currently sitting at 1.49, while the Average True Range indicator is currently displaying 0.21.
To see how Microbot Medical Inc stock has been performing in comparison to its peers in the industry, here are the numbers: MBOT stock’s performance was 0.00% in the latest trading, and 6.25% in the past year.
An evaluation of the daily trading volume of Microbot Medical Inc (NASDAQ:MBOT) indicates that the 3-month average is 4.12 million.
Currently, records show that 34.74 million of the company’s shares remain outstanding. The insiders hold 10.88% of outstanding shares, whereas institutions hold 6.91%. However, since the stock’s price has seen 21.43% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
